Washington, D.C. 20549


Date of Report (Date of earliest event reported): December 1, 2023

Talkspace, Inc.
(Exact name of registrant as specified in its charter)

(State or other jurisdiction of incorporation)
(Commission File Number)
(I.R.S. Employer Identification No.)

Address Not Applicable
Address Not Applicable
(Address of principal executive offices)
(Zip Code)

(212) 284-7206
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a‑12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Name of each exchange
on which registered
Common stock, $0.0001 par value per share
Warrants to purchase common stock
Nasdaq Global Select Market
Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

ITEM 5.02.
On November 2, 2023, the Board of the Directors (the “Board”)  of Talkspace, Inc. (the “Company”), resolved, via unanimous written consent in lieu of a meeting, to increase the size of the Board from seven to nine directors (the “Increase”) and began a search to fill the vacancies created by the Increase.

On December 1, 2023, after reviewing the qualifications, experience and independence of Ms. Liat Ben-Zur and Ms. Swati Abbott (the “New Directors”) and, after recommendation by the Nominating and Corporate Governance Committee, the Board appointed the New Directors via unanimous written consent.   The New Directors will serve as Class III directors and will stand for reelection as Class III directors at the Company’s 2024 annual meeting of stockholders.   After giving effect to the appointment, each Class of directors will have 3 members.

Ms. Ben-Zur, currently an Entrepreneur in Residence at Storm Ventures, a venture firm that specializes in building enterprise leaders, and strategic advisor, is a transformative technology executive with over 27 years of experience in driving digital transformation and product innovation. Previously, as Corporate Vice President at Microsoft, she played a pivotal role in transforming Microsoft’s Consumer businesses, notably turning around two declining services into $14B ventures and spearheading the revival of Microsoft’s Edge browser and the launch of the world's first commercial GPT-4 solution with Bing. Prior to that, as Senior Vice President at Royal Philips, Ms. Ben-Zur led digital initiatives, launching over 30 connected IoT and personal health products. As Senior Director of Product Management at Qualcomm, she led the launch of the company's first open-source IoT project, AllJoyn, turning that into one of the largest IoT common protocol alliances in the world, AllSeen. An expert in mobile, IoT, and AI, Ms. Ben-Zur is known for her strategic insights in disruptive technologies and product-led growth.  Today Ms. Ben-Zur is a strategic advisor coaching leadership teams on product, growth, culture building and how to harness the power of AI to transform markets.

A magna cum laude BSEE graduate from UC Davis and an MBA from UCLA Anderson School of Management, Ms. Ben-Zur is an inventor holding multiple technology patents. Her numerous accolades include being named one of the "7 Rising Stars of Wireless," "4 Women Waves in the World of IoT," and one of Inspiring Fifty's “Most Inspirational Women in Technology.” .

Ms. Abbott is an independent consultant and serves as a board member at Ensign Group, Inc. (ENSG), a company providing post-acute care. Ms. Abbott also served on the board of Magellan Health, Inc. (MGLN) until Magellan’s acquisition by Centene in January 2022. Ms. Abbott has deep experience leading organizations through data insights and analytical transformations. Ms. Abbott previously served as the Chief Executive Officer of Blue Health Intelligence (“BHI”) for eleven years (until April 2022), where she led their initiatives to leverage data insights to develop innovative analytics solutions. Prior to joining BHI, Ms. Abbott served as the President of MEDai, a Reed Elsevier company and leading predictive analytics company that assists healthcare payers and providers. Her leadership and strategic vision led MEDai’s revenue to grow 300% within four years. Prior to joining MEDai, Ms. Abbott served in multiple roles where she led strategic solutions development for medical management data warehousing, quality assurance and risk management, among other areas. Frost and Sullivan recognized Ms. Abbott as one of the Movers and Shakers in healthcare (2010). Ms. Abbott was selected by Directors  Boards publication as one of the Racial and Ethnic Directors to Watch for 2022. Ms. Abbott holds a Bachelor of Science degree in physics from Delhi University, India.

The New Directors will receive up to the Company's standard compensation for non-employee directors in accordance with the Company's Director Compensation Policy, as described in the Company's proxy statement on Schedule 14A filed with the Securities and Exchange Commission on September 1, 2023. The New Directors will execute an indemnification agreement consistent with the Company's standard form of indemnification agreement, filed as an exhibit to the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.

There is no arrangement or understanding between the New Directors and any other persons pursuant to which the New Directors were appointed as directors, and, other than as set forth above, the New Directors have no direct or indirect material interest in any transaction required to be disclosed under Item 404(a) of Regulation S-K.

On December 5, 2023, the Company issued a press release in connection with the announcement of the foregoing matters. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.

Item 9.01.
Financial Statements and Exhibits.

(d) Exhibits

Press Release issued by Talkspace, Inc., dated December 5, 2023.
Cover Page Interactive Data File (embedded within the Inline XBRL document).

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

Talkspace, Inc.
Date:      December 5, 2023
/s/ Jennifer Fulk
Jennifer Fulk
Chief Financial Officer

Exhibit 99.1

Talkspace Announces Appointment of Two New Independent Directors
NEW YORK, Dec. 5, 2023 (GLOBE NEWSWIRE) – Talkspace, Inc. (NASDAQ:TALK) today announced the appointment of Swati Abbott and Liat Ben-Zur to its board of directors as new, independent directors, effective December 1, 2023. With the appointments of Mses. Abbott and Ben-Zur, the board has expanded from seven to nine members, seven of whom are independent.
“We are excited and honored to welcome Ms. Ben-Zur and Ms. Abbott, two accomplished and seasoned business leaders, to our distinguished board of directors,” said Douglas Braunstein, chairman of the board. “They each bring unique experience and perspective that will complement the skills and experience of the current board. We believe that, with Ms. Ben-Zur's experience leading organizations through technological and digital transformations, product innovation and strategic growth and Ms. Abbott's experience as a leader within the payer and provider markets and extensive domain knowledge in data & healthcare analytics, the addition of these two talented individuals will be invaluable to Talkspace during this period of continued growth."
Ms. Abbott is an independent consultant who previously served as Chief Executive Officer of Blue Health Intelligence (BHI), a healthcare data and analytics company spun out of the Blue Cross Blue Shield Association (BCBSA), from 2011 until 2022. During her tenure at BHI, she worked closely with BCBSA to leverage data and advanced analytics to inform provider transparency, establishing high-performance networks and measuring success of value-based care. Prior to joining BHI, Ms. Abbott served as the President of MEDai, a Reed Elsevier company and leading predictive analytics company that assists healthcare payers and providers. Her leadership and strategic vision led MEDai’s revenue to grow 300% within four years.Ms. Abbott previously served on the board of directors of Magellan Health from 2018 to 2022, and is currently on the board of directors for The Ensign Group, a company providing post-acute care, from 2020.
Ms. Ben-Zur has over 27 years of digital product experience in healthcare, software, and consumer businesses. She most recently served as the Corporate Vice President of Consumer Services at Microsoft, where she led efforts to reshape Microsoft's consumer services businesses. During her time at Microsoft, she notably turned around two declining services into $14B ventures and spearheaded the revival of Microsoft’s Edge browser and the launch of the world's first commercial GPT-4 solution with Bing. After more than two decades of leading technology innovations at Microsoft, Royal Philips, and Qualcomm, Ms. Ben-Zur is now serving as an Entrepreneur in Residence at Storm Ventures, and as a strategic advisor coaching leadership teams on product, growth, culture building and how to harness the power of AI to transform markets. Ms. Ben-Zur previously served on the board of directors of Umicore SA from 2017-2021, as well as not-for-profits Allseen Alliance and Tender Loving Care Assistance Dogs, Inc., from 2012-2014 and 2010-2014, respectively.
About Talkspace
Talkspace (Nasdaq: TALK) is a leading virtual behavioral healthcare company committed to helping people lead healthier, happier lives through access to high-quality mental healthcare. At Talkspace, we believe that mental healthcare is core to overall healthcare and should be available to everyone.
Talkspace pioneered the ability to text with a licensed therapist from anywhere and now offers a comprehensive suite of mental health services from self-guided products to individual and couples therapy, in addition to psychiatric treatment and medication management. With Talkspace’s core psychotherapy offering, members are matched with one of thousands of licensed providers across all 50 states and can choose from a variety of subscription plans including live video, text or audio chat sessions and/or asynchronous text messaging.
All care offered at Talkspace is delivered through an easy-to-use, fully-encrypted web and mobile platform that meets HIPAA, federal, and state regulatory requirements. Talkspace covers approximately 113 million lives as of September 30, 2023, through our partnerships with employers, health plans, and paid benefits programs.
For more information, visit www.talkspace.com.
For Investors:
Neal Nagaragan
Sloane & Company
(301) 273-5662
For Media:
John Kim
(310) 997-5963